Kimberly-Clark Operating Income increased by 48.5% to $753.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.3%, from $631.00M to $753.00M. Over 4 years (FY 2021 to FY 2025), Operating Income shows relatively stable performance with a -2.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth in operating income suggests that the core business is becoming more profitable and efficient.
The profit realized from a business's own operations after deducting operating expenses like wages, depreciation, and co...
This is a key metric for comparing the fundamental business performance of companies with different tax or debt structures.
operating_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $613.00M | $657.00M | $521.00M | $693.00M | $621.00M | $655.00M | $712.00M | $787.00M | $113.00M | $774.00M | $254.00M | $853.00M | $539.00M | $1.03B | $282.00M | $631.00M | $592.00M | $621.00M | $507.00M | $753.00M |
| QoQ Change | — | +7.2% | -20.7% | +33.0% | -10.4% | +5.5% | +8.7% | +10.5% | -85.6% | +585.0% | -67.2% | +235.8% | -36.8% | +90.4% | -72.5% | +123.8% | -6.2% | +4.9% | -18.4% | +48.5% |
| YoY Change | — | — | — | — | +1.3% | -0.3% | +36.7% | +13.6% | -81.8% | +18.2% | -64.3% | +8.4% | +377.0% | +32.6% | +11.0% | -26.0% | +9.8% | -39.5% | +79.8% | +19.3% |
| Segment | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 |
|---|---|---|---|---|---|---|---|---|
| Personal Care | $423.00M | $487.00M | $472.00M | $502.00M | $429.00M | $545.00M | $540.00M | $482.00M |
| Corporate and Other | -$114.00M | -$84.00M | -$801.00M | -$128.00M | -$105.00M | -$151.00M | -$227.00M | -$318.00M |
| Consumer Tissue Products | $239.00M | $240.00M | $200.00M | $267.00M | $269.00M | $290.00M | $245.00M | $265.00M |
| Away-from-home Professional Products | $163.00M | $159.00M | $187.00M | $168.00M | $151.00M | $188.00M | $186.00M | $161.00M |
| Total | $712.00M | $787.00M | $113.00M | $774.00M | $254.00M | $853.00M | $539.00M | $1.03B |
Away-from-home Professional Products, Consumer Tissue Products, Corporate and Other, Personal Care were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
| Segment | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|
| NA | — | $676.00M | $655.00M | $640.00M | $582.00M | $623.00M |
| IPC | — | $194.00M | $182.00M | $214.00M | $206.00M | $245.00M |
| International Family Care & Professional (IFP) | — | $106.00M | — | — | — | — |
| International Family Care and Professional (IFP) | $94.25M | — | — | — | — | — |
| Total | $282.00M | $631.00M | $592.00M | $621.00M | $507.00M | $753.00M |
International Family Care and Professional (IFP) is derived from annual filings.
International Family Care & Professional (IFP), International Family Care and Professional (IFP) were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.